Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z-X Shen

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Leukemia|August 23, 2001
Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemiaL Xu, W L Zhao, S M Xiong, et al.
Leukemia|May 23, 2001
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosageY Shen, Z X Shen, H Yan, et al.
Science (New York, N.Y.)|July 10, 2021
Magnetic excitations in infinite-layer nickelatesH Lu, M Rossi, A Nag, et al.
Nature Materials|May 27, 2014
A stable three-dimensional topological Dirac semimetal Cd3As2Z K Liu, J Jiang, B Zhou, et al.
Environmental Science. Processes & Impacts|July 17, 2020
Metallic elements and Pb isotopes in PM<sub>2.5</sub> in three Chinese typical megacities: spatial distribution and source apportionmentH M Xu, K L He, R Feng, et al.
Physical Review Letters|December 7, 2019
Spectroscopic Evidence for Electron-Boson Coupling in Electron-Doped Sr_{2}IrO_{4}Yong Hu, Xiang Chen, S-T Peng, et al.
Scientific Reports|January 23, 2016
Raman and fluorescence characteristics of resonant inelastic X-ray scattering from doped superconducting cupratesH Y Huang, C J Jia, Z Y Chen, et al.
Science (New York, N.Y.)|August 7, 2010
Massive Dirac fermion on the surface of a magnetically doped topological insulatorY L Chen, J-H Chu, J G Analytis, et al.
Physical Review Letters|January 7, 2017
Distinct Electronic Structure for the Extreme Magnetoresistance in YSbJunfeng He, Chaofan Zhang, Nirmal J Ghimire, et al.
Leukemia|April 5, 2017
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trialN J Bahlis, A Corso, L-O Mugge, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Leukemia|August 23, 2001
Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemiaL Xu, W L Zhao, S M Xiong, et al.
Leukemia|May 23, 2001
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosageY Shen, Z X Shen, H Yan, et al.
Science (New York, N.Y.)|July 10, 2021
Magnetic excitations in infinite-layer nickelatesH Lu, M Rossi, A Nag, et al.
Nature Materials|May 27, 2014
A stable three-dimensional topological Dirac semimetal Cd3As2Z K Liu, J Jiang, B Zhou, et al.
Environmental Science. Processes & Impacts|July 17, 2020
Metallic elements and Pb isotopes in PM<sub>2.5</sub> in three Chinese typical megacities: spatial distribution and source apportionmentH M Xu, K L He, R Feng, et al.
Physical Review Letters|December 7, 2019
Spectroscopic Evidence for Electron-Boson Coupling in Electron-Doped Sr_{2}IrO_{4}Yong Hu, Xiang Chen, S-T Peng, et al.
Scientific Reports|January 23, 2016
Raman and fluorescence characteristics of resonant inelastic X-ray scattering from doped superconducting cupratesH Y Huang, C J Jia, Z Y Chen, et al.
Science (New York, N.Y.)|August 7, 2010
Massive Dirac fermion on the surface of a magnetically doped topological insulatorY L Chen, J-H Chu, J G Analytis, et al.
Physical Review Letters|January 7, 2017
Distinct Electronic Structure for the Extreme Magnetoresistance in YSbJunfeng He, Chaofan Zhang, Nirmal J Ghimire, et al.
Leukemia|April 5, 2017
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trialN J Bahlis, A Corso, L-O Mugge, et al.
Pageof 19